Redox-Based Escape Mechanism from Death: The Cancer Lesson
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
We review here current evidence on the role of reactive oxygen species (ROS) and of the intracellular redox state in governing crucial steps of the metastatic process, from cell detachment from the primary tumor to final colonization of the distant site. In particular, we discuss the redox-dependent aspects of cell glycolytic metabolism (Warburg effect), of cell juggling between different motility styles (epithelial-to-mesenchymal and mesenchymal-to-amoeboid transition), of cell resistance to anoikis and of cell interaction with the stromal components of the metastatic niche. Central to this overview is the concept that metastasis can be viewed as an integrated "escape program" triggered by redox changes and instrumental at avoiding oxidative stress within the primary tumor. In this novel perspective, metabolic, motility, and prosurvival choices of the cell along the entire metastatic process can be interpreted as exploiting redox-signaling cascades to monitor oxidative/reductive environmental cues and escape oxidative damage. We also propose that this theoretic framework be applied to "normal" evasion/invasion programs such as in inflammation and development. Furthermore, we suggest that the intimate connection between metastasis, inflammation, and stem cells results, at least in part, by the sharing of a common redox-dependent strategy for infiltration, survival, dissemination, and patterning.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedThe Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088 · cited 1×
“With the trade-off of reduced ATP generation, aerobic glycolysis provides substrates for biosynthetic pathways, including nucleotide, fatty acid, and protein synthesis, necessary to sustain uncontrolled cell proliferation (27).”
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905 · cited 1×
“Additionally, HIF-1 indirectly inhibits mitochondrial respiration through at least two distinct mechanisms: (a) upregulation of the pyruvate dehydrogenase kinase (PDK-1), an enzyme capable of phosphorylating and inactivating mitochondrial pyruvate dehydrogenase, thereby diverting the metabolic fate of pyruvate toward…”
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684 · cited 1×
“One main feature of a successful cancer is its ability to activate an epigenetic program of motility, allowing cancer cells to escape an unfavorable primary site and invade a secondary and more favorable site (17, 64).”
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302 · cited 2×
“EMT illustrates the differentiation plasticity during development, but is commonly exploited by cancer cells to invade and metastasize (111, 153).”
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820 · cited 1×
“Second, M2, the embryonic variant of pyruvate kinase, which is catalytically inefficient and allows upstream accumulation of glycolytic intermediates, is preferentially expressed in malignant cells (24).”
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
Requirement for Generation of H 2 O 2 for Platelet-Derived Growth Factor Signal Transduction
Sundaresan, M., Yu, Z.-X., Ferrans, V. J., Irani, K., & Finkel, T. (1995) · Science · doi:10.1126/science.270.5234.296 · Cited by 2,520
Cancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452 · cited 1×
“, metabolic switch to glycolysis even in the presence of an adequate oxygen supply (61).”
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300 · cited 1×
“Interestingly, hypoxia, inflammation, and resistance to chemoradiation therapy have all been mechanistically linked to an increased risk of tumor dissemination (30, 36, 51, 92).”
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019 · cited 4×
“Loss of p53 leads to reduced expression of two p53 target genes, synthesis of cytochrome oxidase-2 ( SCO 2 ) (93) and Tp53-induced glycolysis and apoptosis regulator ( TIGAR ) (5).”
InfluentialHypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707
Hypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676 · cited 4×
“Consequently, glycolysis is promoted by preventing the assembly of mitochondrial DNA-encoded COX II subunit ( MTCO2 gene) into the COX complex and by increasing the concentration of fructose 2-6 bis-phosphate, a potent activator of glycolysis and inhibitor of gluconeogenesis, respectively.”
Influentialp53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650 · cited 3×
“Metabolic reprogramming toward glycolytic ATP generation involves several molecular players and biochemical mechanisms, including primary mitochondrial dysfunction and mtDNA mutations (62), oncogenic transformation (126), loss of tumor-suppressor genes such as Trp53 (5, 93) and von Hippel–Lindau ( VHL ) (123), and, pr…”
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635 · cited 1×
“First, inhibition of lactate dehydrogenase in aggressive cancer cells restores mitochondrial respiration and, in parallel, reduces proliferation and tumorigenicity in vivo (37).”
Gaggioli, C., Hooper, S., Hidalgo-Carcedo, C., Grosse, R., Marshall, J. F., Harrington, K., & Sahai, E. (2007) · Nature Cell Biology · doi:10.1038/ncb1658 · Cited by 1,589 · cited 1×
“Tumor-associated host cells are themselves invasive, and some of them arrive at the site of metastasis in advance of the cancer cells, thereby protecting cancer cells when circulating and facilitating their invasion (43, 120).”
ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis
Ishikawa, K., Takenaga, K., Akimoto, M., Koshikawa, N., Yamaguchi, A., Imanishi, H., Nakada, K., Honma, Y., & Hayashi, J.-I. (2008) · Science · doi:10.1126/science.1156906 · Cited by 1,444
The impact of O2 availability on human cancer
Bertout, J. A., Patel, S. A., & Simon, M. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2540 · Cited by 1,365 · cited 1×
“The role of HIF-1 in metabolic cell reprogramming, coupled with the finding that HIF-1 expression levels positively correlate with cancer invasiveness and poor prognosis in experimental and clinical settings (7), suggests that HIF-1 may be critical in linking tumor hypoxia, glycolytic energy metabolism, and cancer met…”
Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability
Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., Leake, D., Godden, E. L., Albertson, D. G., Angela Nieto, M., et al. (2005) · Nature · doi:10.1038/nature03688 · Cited by 1,284 · cited 3×
“Additionally, MMPs are known to activate the Rac-1–NOX–ROS signaling cascade on the cancer cell side, favoring invasiveness and genomic instability (115).”
Erler, J. T., Bennewith, K. L., Cox, T. R., Lang, G., Bird, D., Koong, A., Le, Q.-T., & Giaccia, A. J. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.11.012 · Cited by 1,231
HIF-1 Regulates Cytochrome Oxidase Subunits to Optimize Efficiency of Respiration in Hypoxic Cells
Fukuda, R., Zhang, H., Kim, J.-W., Shimoda, L., Dang, C. V., & Semenza, G. L. (2007) · Cell · doi:10.1016/j.cell.2007.01.047 · Cited by 1,225 · cited 3×
“Additionally, HIF-1 indirectly inhibits mitochondrial respiration through at least two distinct mechanisms: (a) upregulation of the pyruvate dehydrogenase kinase (PDK-1), an enzyme capable of phosphorylating and in-activating mitochondrial pyruvate dehydrogenase, thereby diverting the metabolic fate of pyruvate toward…”
Kuwana, T., Bouchier-Hayes, L., Chipuk, J. E., Bonzon, C., Sullivan, B. A., Green, D. R., & Newmeyer, D. D. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.003 · Cited by 1,185 · cited 1×
“The apoptosis sensitizers (Bad, Bik, Bmf, Noxa, Puma, and Hrk) also contribute to cell death by inhibiting Bcl-2, thus allowing the Bax=Bak oligomer to form (77).”
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Kim, S., Takahashi, H., Lin, W.-W., Descargues, P., Grivennikov, S., Kim, Y., Luo, J.-L., & Karin, M. (2009) · Nature · doi:10.1038/nature07623 · Cited by 1,100 · cited 1×
“Intriguingly, another recent work by Karin and co-workers (73) convincingly showed that versican produced by cancer cells can activate myeloid cells through Toll-like receptors (TLR) 2 and 6 to secrete TNF-a and IL-6 (73); in turn, versican and TNF-a are both necessary for Lewis lung carcinoma cells (LLCs) experimenta…”
c-Myc transactivation of LDH-A : Implications for tumor metabolism and growth
Shim, H., Dolde, C., Lewis, B. C., Wu, C.-S., Dang, G., Jungmann, R. A., Dalla-Favera, R., & Dang, C. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6658 · Cited by 1,092 · cited 1×
“Metabolic reprogramming toward glycolytic ATP generation involves several molecular players and biochemical mechanisms, including primary mitochondrial dysfunction and mtDNA mutations (62), oncogenic transformation (126), loss of tumor-suppressor genes such as Trp53 (5, 93) and von Hippel–Lindau (VHL) (123), and, prim…”
Oxidative protein folding in eukaryotes
Tu, B. P., & Weissman, J. S. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200311055 · Cited by 1,041
Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
Dewhirst, M. W., Cao, Y., & Moeller, B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2397 · Cited by 1,022
Gottlob, K., Majewski, N., Kennedy, S., Kandel, E., Robey, R. B., & Hay, N. (2001) · Genes & Development · doi:10.1101/gad.889901 · Cited by 961
Real-time imaging of the intracellular glutathione redox potential
Gutscher, M., Pauleau, A.-L., Marty, L., Brach, T., Wabnitz, G. H., Samstag, Y., Meyer, A. J., & Dick, T. P. (2008) · Nature Methods · doi:10.1038/nmeth.1212 · Cited by 894
Thioredoxin and Related Molecules–From Biology to Health and Disease
Lillig, C. H., & Holmgren, A. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.9.25 · Cited by 724 · cited 1×
“Because the thioredoxin redox state is regulated by NADPH as a cofactor of the thioredoxin reductase (TR) (82) and endoplasmic reticulum stress induced by glucose and nutrient deprivation concomitant with an increase of intracellular ROS (150), both stress cascades linked to metastasis dormancy appear to be redox sens…”
Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer
King, A., Selak, M. A., & Gottlieb, E. (2006) · Oncogene · doi:10.1038/sj.onc.1209594 · Cited by 672 · cited 1×
“Third, metabolic accumulation of succinate and fumarate in the cytosol, due to genetic mitochondrial defects, stabilizes HIF-1 through PDH inhibition (74), and, in human gliomas and other cancer cell lines, the accumulation of HIF-1a protein under aerobic conditions requires the metabolism of glucose to pyruvate (86).”
Park, H. S., Jung, H. Y., Park, E. Y., Kim, J., Lee, W. J., & Bae, Y. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3589 · Cited by 635 · cited 1×
“TLRs activation leads to generation of ROS (105), and TLR2 couples with NADPH oxidase (152).”
Gilmore, A. P. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401723 · Cited by 597
JunD Reduces Tumor Angiogenesis by Protecting Cells from Oxidative Stress
Gerald, D., Berra, E., Frapart, Y. M., Chan, D. A., Giaccia, A. J., Mansuy, D., Pouysségur, J., Yaniv, M., & Mechta-Grigoriou, F. (2004) · Cell · doi:10.1016/j.cell.2004.08.025 · Cited by 588
Regulation of cancer cell metabolism by hypoxia-inducible factor 1
Semenza, G. L. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.11.009 · Cited by 469 · cited 3×
“HIF-1 is a hetero-dimer composed of constitutive, stable b subunits and one of the unstable a (alpha1, alpha2, and alpha3) subunits, which undergo rapid proteasomal degradation because of sequential actions of oxygen-dependent prolyl hydroxylases (PHDs) and the VHL ubiquitin ligase (reviewed in ref.”
Mitochondrial complex III regulates hypoxic activation of HIF
Klimova, T., & Chandel, N. S. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402307 · Cited by 433 · cited 1×
“Of note, hypoxia has been causally linked to an increase in intracellular=mitochondrial ROS, thereby stressing that hypoxic conditions and ROS can act synergistically in inducing metastatic outcomes (75).”
Reactive oxygen species in tumor metastasis
Nishikawa, M. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.031 · Cited by 398
Mitochondria and cellular oxygen sensing in the HIF pathway
Taylor, C. T. (2008) · Biochemical Journal · doi:10.1042/bj20071249 · Cited by 298 · cited 1×
“Chemical inhibitors of ETC reportedly inhibit hypoxic induction of HIF-1 (133), whereas mitochondrial DNA mutations associated with increased generation of ROS promote normoxic accumulation of the factor and, in parallel, metastatic growth (62).”
Ramsey, M. R., & Sharpless, N. E. (2006) · Nature Cell Biology · doi:10.1038/ncb1106-1213 · Cited by 237
Tumor microenvironment and angiogenesis
Nyberg, P. (2008) · Frontiers in Bioscience · doi:10.2741/3173 · Cited by 212
Redox regulation of the hypoxia-inducible factor
Pouysségur, J., & Mechta-Grigoriou, F. (2006) · Biological Chemistry · doi:10.1515/bc.2006.167 · Cited by 186 · cited 2×
“Because HIF-1, the major determinant of the glycolytic switch in malignant cells, is highly sensitive to oxidative stress (42, 54, 113), it is intriguing to represent the ROS–HIF-1 pathway, which is triggered by hypoxia, oncogene activation, or mitochondrial dysfunction, as part of a typical antioxidant circuit (83).”
Bell, E. L., & Chandel, N. S. (2007) · Essays in Biochemistry · doi:10.1042/bse0430017 · Cited by 90 · cited 1×
“ROS are generated in mitochondria of cells exposed to low oxygen (4), a phenomenon further amplified by cyclic”
Cited by
Reactive oxygen species in cancer
Liou, G.-Y., & Storz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,382
ROS signalling in the biology of cancer
Moloney, J. N., & Cotter, T. G. (2018) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.05.023 · Cited by 1,970
Anoikis molecular pathways and its role in cancer progression
Paoli, P., Giannoni, E., & Chiarugi, P. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.026 · Cited by 1,160
“oxidantmilieu, a very common feature of tumor cells and theirmicroenvironment [167].”
BackgroundSelf-citationFiaschi, T., Marini, A., Giannoni, E., Taddei, M. L., Gandellini, P., De Donatis, A., Lanciotti, M., Serni, S., Cirri, P., & Chiarugi, P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1949 · Cited by 578
Self-citationLee, S. Y., Jeong, E. K., Ju, M. K., Jeon, H. M., Kim, M. Y., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0577-4 · Cited by 578
Metadata
- Authors
- Pani, G., Giannoni, E., Galeotti, T., & Chiarugi, P.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2009-11
- Volume
- 11
- Issue
- 11
- Pages
- 2791-2806
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W2080847099
- Cited by
- 91
- References
- 43
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.